임상 데이터 분석 솔루션 시장 규모, 점유율 및 동향 분석 보고서 : 도입 형태별, 용도별, 지역별 및 부문별 예측(2026-2033년)

Clinical Data Analytics Solutions Market Summary

The global clinical data analytics solutions market size was estimated at USD 5.4 billion in 2025 and is projected to reach USD 9.0 billion by 2033, growing at a CAGR of 6.5% from 2026 to 2033. This growth is driven by rapid advancements in artificial intelligence (AI) and machine learning, which enhance diagnostic accuracy by identifying patterns in large datasets such as electronic health records (EHRs) and medical imaging, enabling improved prediction of patient outcomes and disease risks.

The rising demand for personalized diagnostic tests and treatments has led to a significant increase in clinical trials, generating vast volumes of data that require advanced analytics solutions for effective interpretation. This trend is accelerating the adoption of clinical data analytics platforms. For instance, in August 2023, Lokavant introduced a study planning solution that enables contract research organizations and sponsors to optimize site selection and overall study performance. The growing focus on population health management further supports market expansion.

Moreover, several initiatives by market players are strengthening the adoption of advanced analytics tools. For instance, in September 2024, Komodo Health expanded its MapLab platform with the launch of MapAI and MapExplorer, enhancing collaborative analytics and enabling simplified, no-code access to patient, provider, and payer insights through AI-driven capabilities.

Global Clinical Data Analytics Solutions Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical data analytics solutions market report based on deployment, application, and region:

• Deployment Outlook (Revenue, USD Million, 2021 - 2033)
• On-premise
• Cloud-based
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Clinical Decision Support
• Clinical Trials
• Regulatory Compliance
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Deployment
  • 1.1.2. Application
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2
  • 1.9.3. Objective 3

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Deployment outlook
  • 2.2.2. Application outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Data Analytics Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Industry Value Chain Analysis
  • 3.2.1. Reimbursement framework
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing Volume and Complexity of Clinical Data
    • 3.3.1.2. Shift Toward Value-Based Care Models
    • 3.3.1.3. Rising Adoption of AI and Advanced Analytics Technologies
    • 3.3.1.4. Expansion of Precision Medicine and Personalized Healthcare
    • 3.3.1.5. Increasing Demand for Clinical Decision Support Systems (CDSS)
    • 3.3.1.6. Rising prevalence of chronic diseases
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Data privacy and theft issues
    • 3.3.2.2. Lack of skilled professionals
  • 3.3.3. Industry Challenge
• 3.4. Clinical Data Analytics Solutions Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Social landscape
    • 3.4.2.4. Economic landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Clinical Data Analytics Solutions Market: Deployment Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Cloud-based
  • 4.1.2. On-premise
• 4.2. Segment Dashboard
• 4.3. Global Clinical Data Analytics Solutions Market by Deployment Outlook
  • 4.3.1. Cloud-based
    • 4.3.1.1. Cloud-based market estimates and forecast 2021 to 2033 (USD Million)
  • 4.3.2. On-premise
    • 4.3.2.1. On-premise market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Clinical Data Analytics Solutions Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Clinical Decision Support
  • 5.1.2. Clinical Trials
  • 5.1.3. Regulatory Compliance
  • 5.1.4. Others
• 5.2. Segment Dashboard
• 5.3. Global Clinical Data Analytics Solutions Market by Application Outlook
  • 5.3.1. Clinical Decision Support
    • 5.3.1.1. Cinical decision support market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.2. Clinical Trials
    • 5.3.2.1. Clinical trials market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.3. Regulatory Compliance
    • 5.3.3.1. Regulatory compliance market estimates and forecast 2021 to 2033 (USD Million)
  • 5.3.4. Others
    • 5.3.4.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Clinical Data Analytics Solutions Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2025 & 2033
• 6.2. Regional Market Dashboard
• 6.3. Regional Market Snapshot
• 6.4. Market Size, & Forecasts, Volume and Trend Analysis, 2021 to 2033
• 6.5. North America
  • 6.5.1. U.S.
    • 6.5.1.1. Key country dynamics
    • 6.5.1.2. Regulatory framework
    • 6.5.1.3. Competitive scenario
    • 6.5.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.5.2. Canada
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.5.3. Mexico
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.6. Europe
  • 6.6.1. UK
    • 6.6.1.1. Key country dynamics
    • 6.6.1.2. Regulatory framework
    • 6.6.1.3. Competitive scenario
    • 6.6.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.2. Germany
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.3. France
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.4. Italy
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.5. Spain
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.6. Sweden
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.6.8. Norway
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Japan
    • 6.7.1.1. Key country dynamics
    • 6.7.1.2. Regulatory framework
    • 6.7.1.3. Competitive scenario
    • 6.7.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.7.2. China
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.7.3. India
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.7.4. South Korea
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.7.5. Thailand
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.7.6. Australia
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.8. Latin America
  • 6.8.1. Brazil
    • 6.8.1.1. Key country dynamics
    • 6.8.1.2. Regulatory framework
    • 6.8.1.3. Competitive scenario
    • 6.8.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.8.2. Argentina
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
• 6.9. MEA
  • 6.9.1. South Africa
    • 6.9.1.1. Key country dynamics
    • 6.9.1.2. Regulatory framework
    • 6.9.1.3. Competitive scenario
    • 6.9.1.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.9.2. Saudi Arabia
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.9.3. UAE
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.9.4. Kuwait
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Key Company Market Share Analysis, 2025 (%)
• 7.4. Key Company Market Position Analysis, 2025
• 7.5. Company Profiles
  • 7.5.1. Optum (UnitedHealth Group)
    • 7.5.1.1. Company overview
    • 7.5.1.2. Financial performance
    • 7.5.1.3. Product benchmarking
    • 7.5.1.4. Strategic initiatives
  • 7.5.2. Oracle
    • 7.5.2.1. Company overview
    • 7.5.2.2. Financial performance
    • 7.5.2.3. Product benchmarking
    • 7.5.2.4. Strategic initiatives
  • 7.5.3. SAS Institute
    • 7.5.3.1. Company overview
    • 7.5.3.2. Financial performance
    • 7.5.3.3. Product benchmarking
    • 7.5.3.4. Strategic initiatives
  • 7.5.4. IQVIA
    • 7.5.4.1. Company overview
    • 7.5.4.2. Financial performance
    • 7.5.4.3. Product benchmarking
    • 7.5.4.4. Strategic initiatives
  • 7.5.5. Health Catalyst
    • 7.5.5.1. Company overview
    • 7.5.5.2. Financial performance
    • 7.5.5.3. Product benchmarking
    • 7.5.5.4. Strategic initiatives
  • 7.5.6. eClinical Solutions LLC
    • 7.5.6.1. Company overview
    • 7.5.6.2. Financial performance
    • 7.5.6.3. Product benchmarking
    • 7.5.6.4. Strategic initiatives
  • 7.5.7. OSP
    • 7.5.7.1. Company overview
    • 7.5.7.2. Financial performance
    • 7.5.7.3. Product benchmarking
    • 7.5.7.4. Strategic initiatives
  • 7.5.8. BD
    • 7.5.8.1. Company overview
    • 7.5.8.2. Financial performance
    • 7.5.8.3. Product benchmarking
    • 7.5.8.4. Strategic initiatives
  • 7.5.9. Dassault Systemes
    • 7.5.9.1. Company overview
    • 7.5.9.2. Financial performance
    • 7.5.9.3. Product benchmarking
    • 7.5.9.4. Strategic initiatives
  • 7.5.10. Cognizant
    • 7.5.10.1. Company overview
    • 7.5.10.2. Financial performance
    • 7.5.10.3. Product benchmarking
    • 7.5.10.4. Strategic initiatives
  • 7.5.11. Epic Systems
    • 7.5.11.1. Company overview
    • 7.5.11.2. Financial performance
    • 7.5.11.3. Product benchmarking
    • 7.5.11.4. Strategic initiatives
  • 7.5.12. MedeAnalytics
    • 7.5.12.1. Company overview
    • 7.5.12.2. Financial performance
    • 7.5.12.3. Product benchmarking
    • 7.5.12.4. Strategic initiatives
  • 7.5.13. Veradigm
    • 7.5.13.1. Company overview
    • 7.5.13.2. Financial performance
    • 7.5.13.3. Product benchmarking
    • 7.5.13.4. Strategic initiatives
  • 7.5.14. ICON plc
    • 7.5.14.1. Company overview
    • 7.5.14.2. Financial performance
    • 7.5.14.3. Product benchmarking
    • 7.5.14.4. Strategic initiatives
  • 7.5.15. IBM
    • 7.5.15.1. Company overview
    • 7.5.15.2. Financial performance
    • 7.5.15.3. Product benchmarking
    • 7.5.15.4. Strategic initiatives
  • 7.5.16. Arcadia
    • 7.5.16.1. Company overview
    • 7.5.16.2. Financial performance
    • 7.5.16.3. Product benchmarking
    • 7.5.16.4. Strategic initiatives